Skye Peptides review: catalogue, lab reports, shipping (2026)
What Skye Peptides publishes about its catalogue, its lab reports, its shipping and its payment terms, read from skyepeptides.com on September 16, 2026and checked against FDA's warning letter database. A listing is not an endorsement, and we do not verify purity, identity or what is in any individual vial.
This page reports what published studies found. It is not medical advice, no provider-patient relationship is created by reading it, and nothing here is a recommendation to use any compound. Talk with a licensed clinician about your own situation. Read the full disclaimer.
At a glance
| Status | Open |
|---|---|
| Lab reports | Not published We could not confirm a certificate policy from the pages we could read. |
| Ships to | Not published |
| Payment | The shipping and payments page exists but requires an account, so its terms could not be read. |
| FDA warning letters | None found in FDA's warning letter database when we searched it on September 16, 2026. |
| Website | skyepeptides.com |
Sponsored links below; we may earn a commission. Details.
Visit Skye PeptidesPlain link. We are not an affiliate of Skye Peptides at this time.
Compounds listed
Products this vendor lists that match a compound we track, read from its own catalogue. Coded or abbreviated product names are not mapped, because that would mean guessing at what is in the vial.
No catalogue was readable when we checked, so no compounds are recorded for this vendor. Every compound profile carries its own regulatory status regardless of who sells it.
What we found
Skye Peptides is entirely account-gated. On 2026-09-16 the homepage redirected to a login form, and the site's own sitemap lists only 17 pages, all of them account, policy or information pages: about, wholesale, refunds, register, shipping and payments, test reports, knowledge bank, library, cart and checkout. There is no public product sitemap and no readable catalogue.
That means every fact a buyer would want is behind registration. The site does have a test reports page and a shipping and payments page, so the information exists; it is simply not public. We have recorded no compounds for this vendor rather than inferring a catalogue we could not see.
Skye Peptides did not appear in FDA's warning letter database when we searched it on 2026-09-16. A vendor that will not show its catalogue, its certificates or its terms until an account is created is one a reader is asked to trust before seeing anything.
What “research use only” means, and the market it sits in
Every vendor in this section sells material labelled for research, laboratory or analytical use and not for human consumption. That label is not a formality and it is not a loophole. It is the seller stating that the product has not been through the approval or compounding systems that govern medicines, and that it is not intended for a person.
The market is under active enforcement. FDA's public warning letter database shows a continuing run of unapproved-new-drug and misbranding letters to peptide sellers: Gram Peptides and Pink Pony Peptides on 31 March 2026, Wholesale Peptide on 17 June 2026, and five on a single day, 24 August 2026, to Peak Performance Peptides, Royal Peptides, NuScience Peptides, Peptide Partners and Tex Peptides. Of the vendors profiled here, one appears in that database: Swiss Chems, letter dated 10 December 2024.
Criminal exposure is real as well. In the Northern District of Indiana, the operators of Paradigm Peptides entered guilty pleas on 10 December 2025 over products sold as SARMs that in fact contained testosterone and over unapproved peptide and hCG products; both were sentenced in July 2026. Separately, payment processors have been withdrawing from this category, which is why so many storefronts route buyers to crypto, Zelle or bank wire rather than a card.
There is a lawful route for several of these compounds, and it is not this one. At its meeting on 23–24 July 2026, FDA's Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV and TB-500 (8–6, one abstention) and MOTS-c (7–5, two abstentions) for the section 503A bulk drug substances list. That vote is advisory: FDA decides, and where compounding proceeds it runs through a licensed prescriber and a licensed pharmacy, not a research storefront.
Sources for this section
- FDA warning letter database (searched 16 September 2026)
- FDA warning letter to Swisschems, 10 December 2024 (MARCS-CMS 695663)
- FDA warning letter to Gram Peptides, 31 March 2026
- FDA warning letter to Peak Performance Peptides, 24 August 2026
- United States v. Matthew Kawa, N.D. Indiana (guilty pleas entered 10 December 2025)
- FDA Pharmacy Compounding Advisory Committee, 2026 meeting materials (meeting of 23–24 July 2026)
Compound profiles carry the regulatory status for each substance, and online peptide therapy covers the prescription route.
Frequently asked questions
Is Skye Peptides legit?
The domain resolves and a storefront exists behind a login, but nothing about the catalogue, the certificates, the shipping or the payment terms is public, so there is very little to verify from outside. It did not appear in FDA's warning letter database on 2026-09-16.
Why can I not see the Skye Peptides catalogue?
The site requires an account. Its public sitemap lists only account and policy pages, and the shop itself is not exposed. Several research vendors have moved to this model as enforcement has increased.
What do Skye Peptides reviews say?
We do not aggregate reviews for research vendors, and in this case there is no public catalogue to check a review against. The only public facts are the page list and the login requirement.
Does Skye Peptides have a discount code?
Nothing is published outside the login, so no code can be confirmed. We do not issue codes for any vendor listed here.
Does Skye Peptides publish certificates of analysis?
It has a test reports page, but that page requires an account, so we could not read it and the certificate policy is recorded as unknown.
Want it prescribed instead?
Nothing on this page is a route to a peptide for a person. The lawful route runs through a licensed prescriber and a licensed pharmacy, and for several of these compounds it exists today. Our telehealth section compares programs on prescriber type, pharmacy model, whether labs are required, state coverage and published pricing, and each compound profile states what can lawfully be prescribed or compounded right now.
Where the research stands
Our research digests summarise new studies against their primary sources, and are peptides legal explains the difference between an approved drug, a compounded preparation and a research chemical.